Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015 Publisher Pubmed



Iida M¹ ; Kodera Y¹ ; Dodds A² ; Ho AYL³ ; Nivisonsmith I⁴ ; Akter MR⁵ ; Wu T⁶ ; Lie AKW⁷ ; Ghavamzadeh A⁸ ; Kang HJ⁹ ; Ong TC¹⁰ ; Gyi AA¹¹ ; Farzana T¹² ; Baylon H¹³ Show All Authors
Source: Bone Marrow Transplantation Published:2019

Abstract

Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences among nations in this region and various global registries. Since 2008, more than 10,000 HSCTs have been recorded each year by the Asia-Pacific Blood and Marrow Transplantation Group Data Center. Between 2005 and 2015, the greatest increase in the number of HSCTs was observed in Vietnam. Allogeneic HSCT was performed more frequently than autologous HSCT, and a majority of cases involved related donors. Regarding allogeneic HSCT, the use of cord blood has remained steady, especially in Japan, and the number of cases involving related HLA non-identical donors has increased rapidly, particularly in China. The incidence of hemoglobinopathy, a main indication for allogeneic HSCT in India, China, Iran, and Pakistan, increased nearly six-fold over the last decade. Among the 18 participating countries/regions, the transplant rate per population varied widely according to the absolute number of HSCTs and the national/regional population size. We believe that this report will not only benefit the AP region but will also provide information about HSCT to other regions worldwide. © 2019, Springer Nature Limited.